Sara Reardon and Nature magazine
Scientific American
Denied access to some of the best antibiotics developed in the West the Soviet Union invested heavily in the use of bacteriophages — viruses that kill bacteria — to treat infections. Now, faced with the looming spectre of antibiotic resistance, Western researchers and governments are giving phages a serious look. Pharmaceutical companies remain reluctant to get on board because phage therapy, nearly a century old, would be difficult claim intellectual property.
Spread the word